X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    CRO Market Outlook: Growth Potential & Regulatory Obstacles

    As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits

    Centogene, Lifera Join Forces To Improve Multiomic Testing

    EU Pharma Legislation Reform Aims For Affordable Medicines

    Indian Pharma Business May Increase 8-11%, Predicts Alkem

    2028 May See European Pharma Firms Cross US Giants In Sales

    Buyouts Dwindle As Pharma Sector Faces Pricing Concerns

    Unconstitutional Price-Setting Provisions: PhRMA Asserts

    Pharma May Lose Out To Competition Due To EU Health Package

    Pharma Trade Group Sues Biden Admin Over Medicare Drug Costs

    Chronic Pain Gene Discovered By The University Of Oxford

    Cell & Gene Therapy CDMO Market – Steady Growth On The Cards

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    CRO Market Outlook: Growth Potential & Regulatory Obstacles

    As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits

    Centogene, Lifera Join Forces To Improve Multiomic Testing

    EU Pharma Legislation Reform Aims For Affordable Medicines

    Indian Pharma Business May Increase 8-11%, Predicts Alkem

    2028 May See European Pharma Firms Cross US Giants In Sales

    Buyouts Dwindle As Pharma Sector Faces Pricing Concerns

    Unconstitutional Price-Setting Provisions: PhRMA Asserts

    Pharma May Lose Out To Competition Due To EU Health Package

    Pharma Trade Group Sues Biden Admin Over Medicare Drug Costs

    Chronic Pain Gene Discovered By The University Of Oxford

    Cell & Gene Therapy CDMO Market – Steady Growth On The Cards

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Facilities & Operation

China Continues To Attract Multinational Pharma Investment

Content Team by Content Team
8th July 2023
in Facilities & Operation, News

A collection of notable recent developments in the Chinese pharmaceutical industry indicates that despite ongoing political tensions, multinational pharmaceutical companies still find China an appealing market for investment.

AstraZeneca defies geopolitics to bet on China – Financial Times (paywalled)

AstraZeneca’s CEO expressed his excitement about the surge of biotech companies in China and the potential for his company to introduce drugs developed in China to the global market. Despite concerns about “economic coercion” from China and the US scrutinizing Chinese biotech investments, AstraZeneca remains focused on leveraging its position as the leading foreign pharmaceutical company in China.

Moderna looks for opportunities in China after registering legal entity – Reuters

Moderna Inc., a vaccine manufacturer, has established a legal entity in China and is actively seeking opportunities in the country. The registration of Moderna (China) Biotech Ltd in Shanghai signifies the company’s interest in bringing the benefits of its mRNA platform to the Chinese population. Moderna aims to explore the market and contribute to healthcare advancements in China.

Sanofi to up synergy with Chinese pharma market – China Daily

Sanofi, a French pharmaceutical company, plans to enhance its integration into the Chinese pharmaceutical market. It aims to modernize its manufacturing sites and research network in China, collaborate on drug research and development, and share innovative therapies. Sanofi aims to become a “local-multinational” pharmaceutical company, reinforcing its commitment to the Chinese market through increased investment and cross-border integration.

Aurobindo Pharma completes plant installation in China – The Hindu Business Line

Aurobindo Pharma has successfully completed the installation of its plant in China and expects to commence operations in the next fiscal quarter. The company intends to file product applications with Chinese regulators and initiate European exports. Aurobindo Pharma’s expansion plans also include commissioning three other plants, including one in the US, in the near future.

The US is relying more on China for pharmaceuticals — and vice versa – Atlantic Council

The US-China trade relationship is undergoing changes due to the trade war and the impact of the Covid-19 pandemic. While trade in some sectors has decreased, the pharmaceutical industry has experienced significant growth in bilateral trade between the US and China. Pharmaceutical products, particularly advanced medicines like cancer treatments and antibiotics, have become prominent contributors to this trade relationship.

China’s $220 Billion Biotech Initiative Is Struggling to Take Off – Bloomberg (paywalled)

Despite substantial investments and notable initial public offerings, China’s biotech initiative, valued at $220 billion, has faced challenges in gaining momentum. Only this year did the nation approve its first mRNA vaccine. Li Hangwen, a cancer researcher inspired by Moderna Inc., redirected his efforts toward developing a Covid-19 vaccine in response to the outbreak in Wuhan. This development highlights the struggle of China’s biotech industry despite significant investments made in recent years.

Previous Post

CRO Market Outlook: Growth Potential & Regulatory Obstacles

Related Posts

News

CRO Market Outlook: Growth Potential & Regulatory Obstacles

8th July 2023
US - China Trade In Pharmaceuticals Soars In Recent Years
Middle East and South Asia

US – China Trade In Pharmaceuticals Soars In Recent Years

7th July 2023
Pathways Laid Down By The CMS For Drug Price Negotiations
Facilities & Operation

Biotech M&A Is Set For Rebound With Billion-Dollar Deals

7th July 2023
As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits
Drug Development

Centogene, Lifera Join Forces To Improve Multiomic Testing

7th July 2023
News

ACHEMA 2024: Shaping the future of the process industries

6th July 2023
Facilities & Operation

New Guidelines: Medicare To Directly Negotiate Drug Prices

5th July 2023

Latest News

Facilities & Operation

China Continues To Attract Multinational Pharma Investment

8th July 2023
News

CRO Market Outlook: Growth Potential & Regulatory Obstacles

8th July 2023
US - China Trade In Pharmaceuticals Soars In Recent Years
Middle East and South Asia

US – China Trade In Pharmaceuticals Soars In Recent Years

7th July 2023
Pathways Laid Down By The CMS For Drug Price Negotiations
Facilities & Operation

Biotech M&A Is Set For Rebound With Billion-Dollar Deals

7th July 2023
As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits
Drug Development

Centogene, Lifera Join Forces To Improve Multiomic Testing

7th July 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In